Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
49.14
+0.79 (1.63%)
At close: Jul 26, 2024, 4:00 PM
48.18
-0.96 (-1.95%)
After-hours: Jul 26, 2024, 4:46 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.46 billion as of July 26, 2024. Its market cap has increased by 368.96% in one year.
Market Cap
1.46B
Enterprise Value
1.38B
1-Year Change
368.96%
Ranking
Category
Stock Price
$49.14
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.46B, an increase of 912.71%. That is a compound annual growth rate of 180.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 1.41B | 23.73% |
| Dec 29, 2023 | 1.14B | 56.81% |
| Dec 30, 2022 | 726.40M | 402.45% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynavax Technologies | 1.50B |
| InMode | 1.49B |
| Tilray Brands | 1.47B |
| U.S. Physical Therapy | 1.46B |
| Vir Biotechnology | 1.45B |
| Phreesia | 1.40B |
| Longboard Pharmaceuticals | 1.39B |
| Day One Biopharmaceuticals | 1.39B |